Service by

Home Journal Issues Guide for Authors Editorial Board About Journal Aims & Scope


Original Article 


Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer

Amrita Vamne*, Poornimadey Sarkar**, Kiran sodavadiya***.

Abstract
Background: It is the most frequently diagnosed cancer in women worldwide affecting. Risk of cancer increase with the age and it is higher in postmenopausal women. Iron deficiency anaemia is most prevalent in Indian women population. Association of serum iron profile and ferritin could be breakthrough for breast cancer detection and could become a future tumour marker. The aim of present study was to measure the serum ferritin, iron, total iron binding capacity and unbound iron binding capacity concentration in breast cancer patients to find out role of serum biochemical parameters (ferritin, iron, UIBC and TIBC) as biomarkers for diagnosis of breast cancer. Method: Total 100 cases were analysed during a period of 3 years they were histopathologically diagnosed breast cancer patients and age matched 100 healthy controls were taken . Levels of serum trace elements were estimated by colorimetric method SPSS version 17 were used for statistical confirmations. Result: Patients when compared to controls, Serum iron (124.8739.12)and TIBC (318.5 62.97) were significantly lower and serum ferritin (188.93 64.46) is significantly higher (p<0.001)in breast cancer patients and these parameters shows a significant positive correlation with tumour marker CA15-3. Conclusion: Based on findings our study concluded that breast tumours can cause increase serum level of iron ,ferritin and TIBC in female breast cancers patients and suggest that all these biochemical parameters can be used as a diagnostic marker for the follow-up of these breast cancer patients. [A Vamne, Natl J Integr Res Med, 2018; 9(1):1-6]

Key words: Breast cancer, ferritin, iron, diagnostic marker


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Amrita Vamne*
Articles by Poornimadey Sarkar**
Articles by Kiran sodavadiya***
on Google
on Google Scholar
Article Statistics
 Viewed: 117
Downloaded: 40
Cited: 0


How to Cite this Article
Pubmed Style

Vamne A, Sarkar P, sodavadiya K. Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer. NJIRM. 2018; 9(1): 1-6.


Web Style

Vamne A, Sarkar P, sodavadiya K. Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer. http://www.njirm.com/?mno=292767 [Access: April 26, 2018].


AMA (American Medical Association) Style

Vamne A, Sarkar P, sodavadiya K. Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer. NJIRM. 2018; 9(1): 1-6.



Vancouver/ICMJE Style

Vamne A, Sarkar P, sodavadiya K. Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer. NJIRM. (2018), [cited April 26, 2018]; 9(1): 1-6.



Harvard Style

Vamne, A., Sarkar, P. & sodavadiya, K. (2018) Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer. NJIRM, 9 (1), 1-6.



Turabian Style

Vamne, Amrita, Poornimadey Sarkar, and Kiran sodavadiya. 2018. Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer. National Journal of Integrated Research in Medicine, 9 (1), 1-6.



Chicago Style

Vamne, Amrita, Poornimadey Sarkar, and Kiran sodavadiya. "Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer." National Journal of Integrated Research in Medicine 9 (2018), 1-6.



MLA (The Modern Language Association) Style

Vamne, Amrita, Poornimadey Sarkar, and Kiran sodavadiya. "Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer." National Journal of Integrated Research in Medicine 9.1 (2018), 1-6. Print.



APA (American Psychological Association) Style

Vamne, A., Sarkar, P. & sodavadiya, K. (2018) Serum Iron And Ferritin As Diagnostic Marker of Breast Cancer. National Journal of Integrated Research in Medicine, 9 (1), 1-6.



AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

 National Journal of Integrated Research in Medicine

Publication by Association of Health Professionals and Health Educators

Open access peer reviewed Journal -  Publication Ethics Policies for Medical Journals  - Retracted Article 

    eISSN : 0975-9840, pISSN:  2230 - 9969 

Now Indexed in National Library of Medicine Catalog,

Indexed in PubMed (for Selected Citation)

Indexed in Index Medicus for the South-East Asian Region

Indexed in Index Copernicus (IC Value 66.37)

Search Your article in Index Copernicus

ISRA Journal Impact Factor: 5.39,  Scientific Journal Impact Factor = 2.507

WHO-HINARI, Index Scholar,

Science Central.com (Score 23.0)

 

  http://www.impactfactorservice.com/assets/images/logo.png     

Included in Open J-Gate, getCITED, connotea, Open Directory Project,

 EQUATOR Network,Ulrich’s Database of ProQuest, MedWorm Publisher,Connect Journals & EBSCO Publishing, ISC Database, New Jour, PSOAR Database, JournalSeek, ourGlocal Journal Database,Cochrane Menstrual Disorders and Subfertility Group, Islamic world science citation center,   

open access journals search engine, Impact Index, Journal Index,Citefactor.org, Directory of Research Journals Indexing (DRJI), Sjournals Index, Open Academic Journals Index, SIS database

 

 --------------------------------------------------------------------------------

List of Journals Indexed for MEDLINE

The List of Journals Indexed for MEDLINE publication ceased with the 2008 edition. The NLM Catalog can be used to obtain a list of currently indexed MEDLINE titles; select the Limit for Current Subsets called "Currently indexed in MEDLINE."

The List of Serials Indexed for Online Users online publication is designed to provide bibliographic information for serials from which articles are indexed with the MeSH® vocabulary and cited in MEDLINE®, the backbone of the NLM PubMed® database. More detailed bibliographic data and information about indexing coverage for serials cited in MEDLINE/PubMed can be found in LocatorPlus®, the NLM online catalog, and the NLM Catalog, an Entrez database.

Journals Recently Accepted by NLM for Inclusion in MEDLINE lists titles selected by LSTRC which meets three times per year in February, June, and October. Results from those meetings appear online about six weeks after each meeting, both on the Web page and in the NLM Catalog.

Previous print versions of the List of Journals Indexed for MEDLINE might be available from the U.S. Government Printing Office (GPO). Information about ordering documents from GPO is available at http://www.nlm.nih.gov/pubs/pubcat.html#ordering.

 
 



The articles in National Journal of Integrated Research in Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.